Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a hogh-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

H Goldschmidt; Pieter Sonneveld; FW Cremer; Ronnie van der Holt; P Westveer; I Breitkreutz; A Benner; A Glasmacher; LGD Schmidt-Wolf; H Martin; D Hoelzer; AD Ho; HM Lokhorst

doi:10.1007/s00277-003-0685-2

Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a hogh-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

H Goldschmidt, Pieter Sonneveld, FW Cremer, Ronnie van der Holt, P Westveer, I Breitkreutz, A Benner, A Glasmacher, LGD Schmidt-Wolf, H Martin, D Hoelzer, AD Ho, HM Lokhorst

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

37 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	654-659
Number of pages	6
Journal	Annals of Hematology
Volume	82
DOIs	https://doi.org/10.1007/s00277-003-0685-2
Publication status	Published - 2003

Research programs

EMC MM-02-41-03

Access to Document

10.1007/s00277-003-0685-2

http://hdl.handle.net/1765/53122

Cite this

Goldschmidt, H., Sonneveld, P., Cremer, FW., van der Holt, R., Westveer, P., Breitkreutz, I., Benner, A., Glasmacher, A., Schmidt-Wolf, LGD., Martin, H., Hoelzer, D., Ho, AD., & Lokhorst, HM. (2003). Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a hogh-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients. Annals of Hematology, 82, 654-659. https://doi.org/10.1007/s00277-003-0685-2

@article{10072409683047ce856a258011d1373e,

title = "Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a hogh-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients",

author = "H Goldschmidt and Pieter Sonneveld and FW Cremer and {van der Holt}, Ronnie and P Westveer and I Breitkreutz and A Benner and A Glasmacher and LGD Schmidt-Wolf and H Martin and D Hoelzer and AD Ho and HM Lokhorst",

year = "2003",

doi = "10.1007/s00277-003-0685-2",

language = "Undefined/Unknown",

volume = "82",

pages = "654--659",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer Science+Business Media",

}

Goldschmidt, H, Sonneveld, P, Cremer, FW, van der Holt, R, Westveer, P, Breitkreutz, I, Benner, A, Glasmacher, A, Schmidt-Wolf, LGD, Martin, H, Hoelzer, D, Ho, AD & Lokhorst, HM 2003, 'Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a hogh-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients', Annals of Hematology, vol. 82, pp. 654-659. https://doi.org/10.1007/s00277-003-0685-2

TY - JOUR

T1 - Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a hogh-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

AU - Goldschmidt, H

AU - Sonneveld, Pieter

AU - Cremer, FW

AU - van der Holt, Ronnie

AU - Westveer, P

AU - Breitkreutz, I

AU - Benner, A

AU - Glasmacher, A

AU - Schmidt-Wolf, LGD

AU - Martin, H

AU - Hoelzer, D

AU - Ho, AD

AU - Lokhorst, HM

PY - 2003

Y1 - 2003

U2 - 10.1007/s00277-003-0685-2

DO - 10.1007/s00277-003-0685-2

M3 - Article

SN - 0939-5555

VL - 82

SP - 654

EP - 659

JO - Annals of Hematology

JF - Annals of Hematology

ER -